Merck Loses Injunction Bid In Generic Diabetes Drug Suit
An Indian court on Friday rejected Merck Sharp & Dohme Corp.'s request for a preliminary injunction in its patent suit over Glenmark Pharmaceuticals Ltd.'s generic version of Merck's diabetes drugs Januvia...To view the full article, register now.
Already a subscriber? Click here to view full article